TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices February 7, 1997
TCL Archive Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer November 27, 2009
TCL Archive In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress June 16, 1978
TCL Archive Letrozole cuts risk of recurrent breast cancer in post-menopausal women. October 17, 2003
